200 related articles for article (PubMed ID: 34685368)
1. COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance-WHONET-Greece (January 2018-March 2021).
Polemis M; Mandilara G; Pappa O; Argyropoulou A; Perivolioti E; Koudoumnakis N; Pournaras S; Vasilakopoulou A; Vourli S; Katsifa H; Karampatakis T; Papavasiliou A; Petinaki E; Xitsas S; Skoura L; Protonotariou E; Mantzana P; Gartzonika K; Priavali E; Kallinteri A; Giannopoulou P; Charalampaki N; Memezas M; Calina Oana Z; Papadogianni M; Panopoulou M; Koutsidou A; Vatopoulos A; Tryfinopoulou K
Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685368
[TBL] [Abstract][Full Text] [Related]
2. Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance - WHONET-Greece, 2010 to 2017.
Polemis M; Tryfinopoulou K; Giakkoupi P; ; Vatopoulos A
Euro Surveill; 2020 Aug; 25(34):. PubMed ID: 32856583
[TBL] [Abstract][Full Text] [Related]
3. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
Dowzicky MJ; Chmelařová E
J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
[TBL] [Abstract][Full Text] [Related]
5. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
Wang Q; Zhao CJ; Wang H; Yu YS; Zhu ZH; Chu YZ; Sun ZY; Hu ZD; Xu XL; Liao K; Xu YC; Zhang LY; Mei YN; Yang B; Ni YX
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1388-96. PubMed ID: 24025503
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q
BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
9. [Changes and Trends of Drug Resistance of Pathogenic Bacteria in Blood Samples of a Tertiary-Level Teaching Hospital from 2016 to 2020].
Deng J; Kang M; Xie Y; Ma Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):688-695. PubMed ID: 35871742
[TBL] [Abstract][Full Text] [Related]
10. Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
Seifert H; Blondeau J; Lucaßen K; Utt EA
J Glob Antimicrob Resist; 2022 Dec; 31():82-89. PubMed ID: 35948242
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital.
Yang W; Ji X
Heliyon; 2020 May; 6(5):e03965. PubMed ID: 32490228
[TBL] [Abstract][Full Text] [Related]
13. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
Kanj SS; Whitelaw A; Dowzicky MJ
Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
Balode A; Punda-Polić V; Dowzicky MJ
Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
[TBL] [Abstract][Full Text] [Related]
17. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
[TBL] [Abstract][Full Text] [Related]
18. Increment Antimicrobial Resistance During the COVID-19 Pandemic: Results from the Invifar Network.
López-Jácome LE; Fernández-Rodríguez D; Franco-Cendejas R; Camacho-Ortiz A; Morfin-Otero MDR; Rodríguez-Noriega E; Ponce-de-León A; Ortiz-Brizuela E; Rojas-Larios F; Velázquez-Acosta MDC; Mena-Ramírez JP; Rodríguez-Zulueta P; Bolado-Martínez E; Quintanilla-Cazares LJ; Avilés-Benítez LK; Consuelo-Munoz S; Choy-Chang EV; Feliciano-Guzmán JM; Couoh-May CA; López-Gutiérrez E; Molina-Jaimes A; Rincón-Zuno J; Gil-Veloz M; Alcaraz-Espejel M; Corte-Rojas RE; Gómez-Espinosa J; Monroy-Colin VA; Morales-de-la-Peña CT; Aguirre-Burciaga E; López-Moreno LI; Martínez-Villarreal RT; Cetina-Umaña CM; Galindo-Méndez M; Soto-Nieto GI; Cobos-Canul DI; Moreno-Méndez MI; Tello-Gómez E; Romero-Romero D; Quintana-Ponce S; Peralta-Catalán R; Valadez-Quiroz A; Molina-Chavarría A; Padilla-Ibarra C; Barroso-Herrera-Y-Cairo IE; Duarte-Miranda LS; López-López DM; Escalante-Armenta SP; Osorio-Guzmán MJ; López-García M; Garza-Ramos U; Delgado-Enciso I; Garza-González E
Microb Drug Resist; 2022 Mar; 28(3):338-345. PubMed ID: 34870473
[No Abstract] [Full Text] [Related]
19. Prevalence of antimicrobial resistance in Gram-negative clinical isolates from a major secondary hospital in Kuwait: a retrospective descriptive study.
Alali WQ; AlFouzan W; Dhar R
Germs; 2021 Dec; 11(4):498-511. PubMed ID: 35096667
[TBL] [Abstract][Full Text] [Related]
20. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Zhang X; Gu B; Mei Y; Wen Y; Xia W
J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
